Abstract:Delong Li, 1 Debin Meng, 1, 2 Rungui Niu 1 1 Department of Special Geriatrics, Shanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China; 2 Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China Correspondence: Debin Meng Department of Special Geriatrics, Shanxi Cancer Hospital, No. 3 Worker Street of Xinghualing District, Taiyuan City, Shanxi Province, People's Republic of China Email debinmengsx@sina.com Introduction: Non-small lung cancer (NSCLC) is one of the most common malignant tumors in the world. Chemoresistance is the main reason of adverse effects leading to the death of patients; thus, it is important to discover the potential target of chemotherapeutic resistance. Methods: The expression of differentially expressed miRNA was detected in BEAS-2B, A549 and A549/cisplatin (DDP) by qRT-PCR. Transmission electron microscopy (TEM) and exosome biomarkers were used to validate the extracted exosome. Cells incubated with miR-613 enriched exosomes were used to detect the function of exo-miR-613 in vitro. Then, exo-miR-613 was injected to mice treated with DDP to investigate the function role of exo-miR-613 in vivo. Results: Comparing to BEAS-2B, the expression of miR-613 inA549 was significantly reduced, which was more obvious in A549/DDP. After incubated with exo-miR-613 and corresponding exo-negative control (NC), we found overexpression of miR-613 remarkably increased the inhibition of cell proliferation induced by cisplatin. Exo-miR-613 fused into cells to significantly enhance the inhibited effect of DDP on the proliferation, migration and showed a promotion on cell apoptosis and DNA damage. The in vivo study showed that exo-miR-613 significantly inhibited the tumor growth, and promote the sensitivity to DDP, probably by down-regulating the expressions of GJA1, TBP and EIF-4E in tumor cells and tissues. Conclusion: Exo-miR-613 reversed chemoresistance to DDP in NSCLC cell to involve in the process of tumor progression, and might be a potential therapeutic strategy for NSCLC. Keywords: exosome, miRNA, non-small cell lung cancer, cisplatin, chemoresistance, apoptosis

Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer In Vivo and Reverse Cisplatin Resistance.

The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Against Cisplatin-Induced Ovarian Granulosa Cell Stress and Apoptosis in Vitro

Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell.

Exosome Mediated Cytosolic Cisplatin Delivery Through Clathrin-Independent Endocytosis and Enhanced Anti-cancer Effect Via Avoiding Endosome Trapping in Cisplatin-Resistant Ovarian Cancer.

Exosomal Transfer of Tumor-Associated Macrophage-Derived Mir-21 Confers Cisplatin Resistance in Gastric Cancer Cells

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer

M1 macrophage-derived exosome-encapsulated cisplatin can enhance its anti-lung cancer effect.

Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7

Effects of exosomes from human umbilical cord mesenchymalstem cells on cisplatin chemotherapy

Hucmsc-Derived Exosomes Protect Ovarian Reserve and Restore Ovarian Function in Cisplatin Treated Mice

NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions

hUCMSC-derived extracellular vesicles relieve cisplatin-induced granulosa cell apoptosis in mice by transferring anti-apoptotic miRNAs

Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613

Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1

The Reversal Effect of Magnetic Fe3O4 Nanoparticles Loaded with Cisplatin on SKOV3/DDP Ovarian Carcinoma Cells.

Exosomes Serve As Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.

M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine

Lung‐specific exosomes for co‐delivery of CD47 blockade and cisplatin for the treatment of non–small cell lung cancer

Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment

Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2.